CARDIOVASCULAR EFFECTS BASED ON MAGNITUDE OF WEIGHT LOSS (WL) IN OBESE/OVERWEIGHT SUBJECTS WITH HYPERTENSION RECEIVING PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE (PHEN/TPM ER)

被引：0

作者：

Bakris, George ^{[1
]}

Davidson, Michael H. ^{[1
]}

Gupta, Alok K. ^{[2
]}

机构：

[1] Univ Chicago, Pritzker Sch Med, ASH Comprehens Hypertens Ctr, Chicago, IL 60637 USA

[2] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA

来源：

JOURNAL OF CLINICAL HYPERTENSION | 2013年 / 15卷 / 07期

关键词：

Phentermine and Topiramate Extended-release; Obesity; Hypertension; Weight loss;

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：517 / 517

页数：1

共 29 条

[1] EFFECT OF WEIGHT LOSS (WL) ON CONCOMITANT MEDICATION COSTS IN OBESE/OVERWEIGHT INDIVIDUALS WITH METABOLIC SYNDROME (METS) RECEIVING PHENTERMINE/TOPIRAMATE EXTENDED-RELEASE (PHEN/TPM ER)
Kahan, S.
Karnawat, S.
VALUE IN HEALTH, 2015, 18 (03) : A297 - A297
[2] Weight Loss (WL) With Phentermine and Topiramate Extended-Release (PHEN/TPM ER) and Change in Glycemic Parameters in Overweight and Obese Adults With Dysglycemia and Stratified by Baseline Body Mass Index (BMI)
Ryan, Donna H.
Bowden, Charles H.
DIABETES, 2013, 62 : A540 - A540
[3] WEIGHT LOSS WITH PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE IN OBESE AND OVERWEIGHT SUBJECTS OVER 56 WEEKS
Kushner, Robert F.
Varghese, Santosh T.
JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 : S241 - S241
[4] Effects of phentermine and topiramate extended-release (PHEN/TPM ER) on weight loss (WL) and glycaemic parameters by gender, race, and baseline body mass index (BMI)
Toplak, H.
Rossner, S.
Dvorak, R.
DIABETOLOGIA, 2013, 56 : S259 - S259
[5] Changes in Glycemic Parameters and Antidiabetic Medication Use by Degree of Weight Loss (WL) With Lifestyle Modification and Phentermine/Topiramate Extended-Release (PHEN/TPM ER)
Kushner, Robert
Troupin, Barbara
DIABETES, 2013, 62 : A544 - A545
[6] COMORBIDITY COST SAVINGS OVER 2 YEARS OF TREATMENT WITH PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE (PHEN/TPM ER) IN AN OVERWEIGHT AND OBESE POPULATION
Carlton, R.
Zagadailov, E.
Bramley, T.
Liu, W.
Kamawat, S.
McDowell, J.
VALUE IN HEALTH, 2014, 17 (03) : A108 - A108
[7] EFFECTS OF PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE (PHEN/TPM ER) TREATMENT ON WEIGHT LOSS (WL) WHEN STRATIFIED BY BASELINE BODY MASS INDEX (BMI) OVER 1 YEAR
Ryan, D.
Church, T.
Karnawat, S.
Troupin, B.
VALUE IN HEALTH, 2013, 16 (03) : A112 - A112
[8] Improved Cardiometabolic Risk Factors in Overweight/Obese Subjects Receiving Controlled-Release Phentermine/Topiramate (PHEN/TPM CR)
Cheskin, Lawrence J.
Peterson, Craig A.
DIABETES, 2012, 61 : A710 - A710
[9] Weight loss and improvements in cardiometabolic outcomes with extended-release phentermine/topiramate treatment in overweight/obese subjects with type 2 diabetes
Astrup, A. V.
Oppert, J. -M.
Peterson, C. A.
DIABETOLOGIA, 2012, 55 : S284 - S285
[10] Effects of extended-release phentermine/topiramate on weight loss and blood pressure in obese subjects with type 2 diabetes mellitus
Rossner, S. K.
Sharma, A. M.
Troupin, B.
Padwal, R. S.
DIABETOLOGIA, 2012, 55 : S285 - S285

← 1 2 3 →